Study to Test the Safety, Tolerability and Efficacy of UCB7665 in Subjects With Moderate to Severe Myasthenia Gravis
Clinical trial NCT03052751 · COMPLETED
Trial details
- NCT number
- NCT03052751
- Sponsor
- UCB Biopharma S.P.R.L.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-15
- Primary completion
- 2018-05-31
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.